These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 19473084)
1. Evaluation of angiotensinogen c.1-44G>A and p.M268T variants as risk factors for fibrosis progression in chronic hepatitis C and liver diseases of various etiologies. Halangk J; Berg T; Neumann K; Sarrazin C; Hinrichsen H; Fitz C; Puhl G; Mueller T; Neuhaus P; Wiedenmann B; Witt H Genet Test Mol Biomarkers; 2009 Jun; 13(3):407-14. PubMed ID: 19473084 [TBL] [Abstract][Full Text] [Related]
2. Relevance of endotoxin receptor CD14 and TLR4 gene variants in chronic liver disease. Von Hahn T; Halangk J; Witt H; Neumann K; Müller T; Puhl G; Neuhaus P; Nickel R; Beuers U; Wiedenmann B; Berg T Scand J Gastroenterol; 2008; 43(5):584-92. PubMed ID: 18415752 [TBL] [Abstract][Full Text] [Related]
3. Host genetic factors influence disease progression in chronic hepatitis C. Powell EE; Edwards-Smith CJ; Hay JL; Clouston AD; Crawford DH; Shorthouse C; Purdie DM; Jonsson JR Hepatology; 2000 Apr; 31(4):828-33. PubMed ID: 10733535 [TBL] [Abstract][Full Text] [Related]
4. Genetic variants of ACE (Insertion/Deletion) and AGT (M268T) genes in patients with diabetes and nephropathy. Shaikh R; Shahid SM; Mansoor Q; Ismail M; Azhar A J Renin Angiotensin Aldosterone Syst; 2014 Jun; 15(2):124-30. PubMed ID: 24737640 [TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Lovati E; Richard A; Frey BM; Frey FJ; Ferrari P Kidney Int; 2001 Jul; 60(1):46-54. PubMed ID: 11422735 [TBL] [Abstract][Full Text] [Related]
6. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection. Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210 [TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Buraczyńska M; Pijanowski Z; Spasiewicz D; Nowicka T; Sodolski T; Widomska - Czekajska T; Ksiazek A Kardiol Pol; 2003 Jan; 58(1):1-9. PubMed ID: 14502296 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection. Halangk J; Sarrazin C; Neumann K; Puhl G; Mueller T; Teuber G; Klinker H; Hinrichsen H; Buggisch P; Landt O; Weich V; Bergk A; Wiedenmann B; Neuhaus P; Berg T; Witt H J Hepatol; 2008 Sep; 49(3):339-45. PubMed ID: 18644651 [TBL] [Abstract][Full Text] [Related]
9. [The relationship between the variants in 5' upstream core promoter A(-6)G and A(-20)C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang]. Li NF; Zhou L; Wu WD; Shi Y; Wang XL; Wang J; Li HJ; Zhang DL; Zu H; Ouyang WJ; Bu KL; Zhou KM; Cheng QY; Guli N; Zhu DH Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):23-8. PubMed ID: 14767903 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease. Eurich D; Bahra M; Boas-Knoop S; Lock JF; Golembus J; Neuhaus R; Neuhaus P; Neumann UP Liver Transpl; 2011 Mar; 17(3):279-88. PubMed ID: 21384510 [TBL] [Abstract][Full Text] [Related]
11. [Genetic risk factors for hepatic fibrosis in chronic liver diseases]. Wasmuth HE; Lammert F; Matern S Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677 [TBL] [Abstract][Full Text] [Related]
12. Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C. Falleti E; Cmet S; Fabris C; Bitetto D; Cussigh A; Fornasiere E; Bignulin E; Feruglio C; Mosanghini E; Fontanini E; Pirisi M; Toniutto P Cytokine; 2012 Jan; 57(1):68-73. PubMed ID: 22122913 [TBL] [Abstract][Full Text] [Related]
13. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients. Bader El Din NG; Salum GM; Anany MA; Ibrahim MK; Dawood RM; Zayed N; El Abd YS; El-Shenawy R; El Awady MK J Interferon Cytokine Res; 2015 Aug; 35(8):641-8. PubMed ID: 25868067 [TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the promoter region of the angiotensinogen gene are associated with liver cirrhosis in patients with chronic hepatitis B. Xiao F; Wei H; Song S; Li G; Song C J Gastroenterol Hepatol; 2006 Sep; 21(9):1488-91. PubMed ID: 16911698 [TBL] [Abstract][Full Text] [Related]
15. [Studies of the association between angiotensinogen gene regulation and cytokines in essential hypertension]. Wang AL; Yu YX; Xu Y; Liu P; Chen ZP; Zhang L; Wu JX; Sun GM; Chen S Yi Chuan Xue Bao; 2003 Oct; 30(10):978-82. PubMed ID: 14669517 [TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection. Suzuki S; Tanaka Y; Orito E; Sugauchi F; Hasegawa I; Sakurai M; Fujiwara K; Ohno T; Ueda R; Mizokami M J Gastroenterol Hepatol; 2003 Oct; 18(10):1139-43. PubMed ID: 12974899 [TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin-aldosterone system related gene polymorphisms and urinary total arsenic is related to chronic kidney disease. Chen WJ; Huang YL; Shiue HS; Chen TW; Lin YF; Huang CY; Lin YC; Han BC; Hsueh YM Toxicol Appl Pharmacol; 2014 Sep; 279(2):95-102. PubMed ID: 24907556 [TBL] [Abstract][Full Text] [Related]
20. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients. Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]